Aquestive Therapeutics, Inc. (AQST)
Data as of , from SEC Form 4 filings.
See up to 3 months of AQST. The 7-day demo opens the 1M and 3M ranges and puts AQST on your watchlist.
Start 7-day demoLatest AQST insider trades
About Aquestive Therapeutics, Inc. (AQST)
The SEC lists Aquestive Therapeutics, Inc. under CIK 0001398733, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
AQST Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 83,750 | $374K |
| Option exercise | 2 | 17,500 | |
| Tax withholding / forfeiture | 1 | 2,714 | |
AQST insider transactions (Form 4)
3957 Form 4 filings on record, the earliest from Nov 27, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Open-market sale | Common Stock | 25,000 | $4.82 footnote F1 | $120K | ||
| ||||||
| Sherry Korczynski - Officer | Option exercise | Common Stock | 8,750 | $2.65 | $23K | |
| Sherry Korczynski - Officer | Open-market sale | Common Stock | 8,750 | $5.22 | $46K | |
| Sherry Korczynski - Officer | Option exercise | Non-Qualified Stock Option (right to buy) | 8,750 | $0.00 | - | |
| Peter E. Boyd - Officer | Other | Common Stock | 2,293 footnote F1 | $0.96 footnote F1 | $2K | |
| Peter E. Boyd - Officer | Other | Warrant (Right to Buy) | 2,293 | $0.00 | - | |
| ||||||
| Other | Common Stock | 91,743 footnote F1 | $0.96 footnote F1 | $88K | ||
| Other | Warrant (Right to Buy) | 91,743 | $0.00 | - | ||
| ||||||
| Other | Common Stock | 4,587 footnote F1 | $0.96 footnote F1 | $4K | ||
| Other | Warrant (Right to Buy) | 4,587 | $0.00 | - | ||
| ||||||
| Open-market sale | Common Stock | 25,000 | $4.29 footnote F1 | $107K | ||
| ||||||
| Sherry Korczynski - Officer | Tax withholding / forfeiture | Common Stock | 2,714 footnote F1 | $4.25 | $12K | |
| ||||||
| Open-market sale | Common Stock | 4,631 | $4.03 footnote F1 | $19K | ||
| Open-market sale | Common Stock | 20,369 | $4.00 footnote F2 | $82K | ||
| ||||||
| Option exercise | Common Stock | 25,000 | $0.71 | $18K | ||
| Open-market sale | Common Stock | 25,000 | $5.02 | $125K | ||
| Option exercise | Non-Qualified Stock Option (right to buy) | 25,000 | $0.00 | - | ||
| Open-market sale | Common Stock | 25,000 | $4.16 footnote F1 | $104K | ||
| ||||||
| Timothy E. Morris | Grant or award | Stock Option (right to purchase) | 50,500 | $0.00 | - | |
| Grant or award | Stock Option (Right to Purchase) | 50,500 | $0.00 | - | ||
| Grant or award | Non-Qualified Stock Option (right to buy) | 50,500 | $0.00 | - | ||
| John Cochran | Grant or award | Stock Option (Right to Purchase) | 50,500 | $0.00 | - | |
| Grant or award | Stock Option (Right to Purchase) | 50,500 | $0.00 | - | ||
| Marco Taglietti | Grant or award | Stock Option (Right to Purchase) | 50,500 | $0.00 | - | |
| Sherry Korczynski - Officer | Tax withholding / forfeiture | Common Stock | 2,714 footnote F1 | $0.00 | - | |
| ||||||
| Thomas A. Zalewski - Officer | Grant or award | Common Stock | 100,000 footnote F1 | $0.00 | - | |
| Thomas A. Zalewski - Officer | Grant or award | Non-Qualified Stock Option (right to buy) | 75,000 | $0.00 | - | |
| ||||||
| Open-market sale | Common Stock | 8,257 | $4.29 footnote F1 | $35K | ||
| ||||||
| Melina Cioffi - Officer | Tax withholding / forfeiture | Common Stock | 1,667 footnote F1 | $4.17 | $7K | |
| ||||||
| Lori J. Braender - Officer | Tax withholding / forfeiture | Common Stock | 135,690 footnote F1 | $4.23 | $574K | |
| ||||||
| Peter E. Boyd - Officer | Tax withholding / forfeiture | Common Stock | 56,778 footnote F1 | $4.18 | $237K | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 335,922 footnote F1 | $4.18 | $1.40M | ||
| ||||||
| A. Ernest Toth Jr. - Officer | Tax withholding / forfeiture | Common Stock | 92,652 footnote F1 | $4.18 | $387K | |
| ||||||
| Tax withholding / forfeiture | Common Stock | 72,734 footnote F1 | $4.18 | $304K | ||
| ||||||
| Lori J. Braender - Officer | Tax withholding / forfeiture | Common Stock | 76,147 footnote F1 | $4.18 | $318K | |
| ||||||
| Grant or award | Performance Stock Units | 293,100 | $0.00 | - | ||
| Peter E. Boyd - Officer | Grant or award | Performance Stock Units | 60,000 | $0.00 | - | |
| Grant or award | Performance Stock Units | 60,000 | $0.00 | - | ||
| A. Ernest Toth Jr. - Officer | Grant or award | Performance Stock Units | 82,500 | $0.00 | - | |
Recent AQST Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Daniel Barber | Director, Officer | 50,000 | $244K | View on EDGAR | |
| Sherry M. Korczynski | Officer | 8,750 |
AQST insider trading FAQ
What is the latest insider trade for AQST?
Aquestive Therapeutics, Inc. (AQST) had 8 insider filings in the last 90 days, with the most recent on 2026-09-16. The full record for AQST runs to 57 Form 4 filings, the earliest from 2024-11-27. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AQST stock?
No insider purchases of AQST were filed in the last 90 days.
How many insiders are selling AQST stock?
5 insider sales of AQST were filed in the last 90 days, totaling $374K.
Where can I see AQST SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AQST Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Daniel Barber view on EDGAR
- - Sherry Korczynski view on EDGAR
- - Peter E. Boyd view on EDGAR
- - Daniel Barber view on EDGAR
- - Cassie Jung view on EDGAR
- - Daniel Barber view on EDGAR
- - Sherry Korczynski view on EDGAR
- - Daniel Barber view on EDGAR
- - Julie Krop view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AQST's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AQST with a 7-day demo
- AQST on your watchlist
- Every AQST Form 4 filing on record
- Up to 3 months of AQST price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive